Fig. 1
From: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
Swimmer plot on dose intensity of afatinib in BM+ patients. Individual swimmer plots for each patient with BM and started on 30 mg OD vs 40 mg OD afatinib, depicting duration and time of intracranial and extracranial disease progression (PD) on different doses of afatinib